Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Xilio Therapeutics (XLO)
- 8.570
- +0.220+2.63%
Close Apr 17 16:00 ET
- 8.000
- -0.570-6.65%
Post 20:01 ET
49.56MMarket Cap-2.05P/E (TTM)
8.760High8.310Low40.39KVolume8.610Open8.350Prev Close343.30KTurnover1.17%Turnover RatioLossP/E (Static)5.78MShares16.52052wk High1.40P/B29.54MFloat Cap6.46552wk Low--Dividend TTM3.45MShs Float391.300Historical High--Div Yield TTM5.39%Range %6.454Historical Low8.499Avg Price1Lot Size
Xilio Therapeutics (XLO) Key Financial Indicators
XLO Earnings per Share (EPS)
According to the latest financial report of Xilio Therapeutics, the latest earnings per share (TTM) for the company is 0.81. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
XLO Free Cash Flow (FCF)
Interested in knowing about Xilio Therapeutics's free cash flow? The latest report shows it as -2.09M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
XLO Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Xilio Therapeutics shows that the company's current ratio is 2.58, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
XLO Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Xilio Therapeutics, the quick ratio is 2.53, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
XLO Return on Equity (ROE)
Want to learn more about the financial health of Xilio Therapeutics? The latest ROE figure is 76.24%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
XLO Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Xilio Therapeutics, the total asset return on investment (ROA) is 7.19%.
Currency: USD
Quarterly
Loading...
XLO Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Xilio Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
XLO Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Xilio Therapeutics, the net profit margin is 75.70%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm